HeartSciences Files Proxy Statement for Business Combination with Fortitude Mining Holdings
HeartSciences Inc. (Nasdaq: HSCS; HSCSW) has filed a preliminary proxy statement regarding a proposed business combination with Fortitude Mining Holdings, Inc., which it believes offers significant value creation potential for shareholders. The company also reported its fiscal year 2026 financial results and provided an update on recent developments. Fiscal 2026 marked key milestones including the full commercial launch of HeartSciences' MyoVista Insights platform and submission of the MyoVista wavECG device to the FDA for 510(k) clearance. Despite these advancements, the company has faced challenges such as sustained pressure on its share price and Nasdaq listing deficiencies. HeartSciences cited Fortitude's strong position in the Zcash mining ecosystem—having mined approximately 28% of overall ZEC production over six months—as a key reason for pursuing this transaction. The proposed deal is seen as an opportunity to leverage institutional interest growing around Zcash, which has shown strong performance among large-cap digital assets.
Topics: business combination financial results proxy statement SEC filing